Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer Seeks To Nearly Double Shares Of Indian Pfizer Arm

This article was originally published in PharmAsia News

Executive Summary

U.S.-based Pfizer, which already owns 41.2 percent of its Indian subsidiary, Pfizer Ltd., is offering to buy another 33.8 percent to give it 75 percent ownership. The $136 million offer by Pfizer tracks a similar move just weeks earlier by Swiss drug maker Novartis, which sought to increase control of its Indian unit, Novartis India. If Indian regulators approve, Pfizer's offer to shareholders is expected to open in June. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts